Introduction: Positive inotropy by calcium sensitization - An evolving approach for the treatment of end-stage heart failure

American Journal of Cardiology

Volumn 83, Issue 12 B, 1999, Pages 1-3

  Papp, Julius Gy ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; LEVOSIMENDAN; MILRINONE;

CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DRUG EFFECT; HEALTH CARE COST; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HUMAN; INOTROPISM; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0033600169     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9149(99)00309-4     Document Type: Conference Paper

References (8)

1. th Annual Scientific Sessions of the American College of Cardiology. New Orleans, LA: 1999.
2. McMurray J.J.V., Petrie M.C., Murdoch D.R., Davie A.P. Clinical epidemiology of heart failure public and private health burden . Eur Heart J. 19:(suppl P):1998;P9-P16.
3. Stevenson L.W. Inotropic therapy for heart failure. N Engl J Med. 339:1998;1848-1850.
4. Packer M., Cohn J.N. Consensus recommendations for the management of chronic heart failure. Am J Cardiol. 83:1999;1A-38A.
5. Hasenfuss G., Pieske B., Castell M., Kretschmann B., Maier L.S., Just H. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation. 98:1998;2141-2147.
6. Packer M., Carver J.R., Rodeheffer R.J., et al. Effect of milrinone on mortality in severe chronic heart failure. N Engl J Med. 325:1993;1468-1475.
7. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 336:1997;525-533.
8. Cohn J.N., Goldstein S.O., Greenberg B.H., Lorell B.H., Bourge R.C., Jaski B.E., Gottlieb S.O., McGrew F., DeMets D., White B.G. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N Engl J Med. 339:1998;1810-1816.